What is a stock summary page? Click here for an overview.
Business Description
Sensorion SA
ISIN : FR0012596468
Compare
Compare
Traded in other countries / regions
ALSEN.FranceRFM.GermanySENOF.USA IPO Date
2015-04-21Description
Sensorion SA is a France-based clinical-stage biotech company dedicated to developing therapies to restore, treat, and prevent hearing loss. The company's product is in phase 2a clinical development, SENS-401 (Arazasetron) in Sudden Sensorineural Hearing Loss (SSNHL). SENS-401 is being developed to treat cochlear pathologies. The Company does business in a single operating segment: conducting research and development to discover drugs to treat inner ear disorders with a view to their future marketing. The company's pipeline programs are SENS-401 SSNHL, SENS-401 CIO, GJB2-GT, GJB2-GT, SENS-401 Cochlear, and others.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 34.98 | |||||
| Equity-to-Asset | 0.81 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.09 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 20.9 | |||||
| 3-Year EPS without NRI Growth Rate | 22 | |||||
| 3-Year FCF Growth Rate | 17.9 | |||||
| 3-Year Book Growth Rate | -22.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 28.08 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.74 | |||||
| 9-Day RSI | 22.15 | |||||
| 14-Day RSI | 23.6 | |||||
| 3-1 Month Momentum % | -5.35 | |||||
| 6-1 Month Momentum % | -17.53 | |||||
| 12-1 Month Momentum % | -21.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.28 | |||||
| Quick Ratio | 6.28 | |||||
| Cash Ratio | 5.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -52.6 | |||||
| Shareholder Yield % | -54.43 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -41.25 | |||||
| ROA % | -32.83 | |||||
| ROIC % | -302.03 | |||||
| 3-Year ROIIC % | -543.27 | |||||
| ROC (Joel Greenblatt) % | -908.81 | |||||
| ROCE % | -38.41 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 207.5 | |||||
| PB Ratio | 1.75 | |||||
| Price-to-Tangible-Book | 1.71 | |||||
| EV-to-EBIT | -1.89 | |||||
| EV-to-Forward-EBIT | -1.22 | |||||
| EV-to-EBITDA | -2.05 | |||||
| EV-to-Forward-EBITDA | -1.22 | |||||
| EV-to-Forward-Revenue | 8.04 | |||||
| EV-to-FCF | -2.16 | |||||
| Price-to-GF-Value | 0.71 | |||||
| Price-to-Net-Current-Asset-Value | 1.78 | |||||
| Price-to-Net-Cash | 2.05 | |||||
| Earnings Yield (Greenblatt) % | -52.96 | |||||
| FCF Yield % | -18.24 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sensorion SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.09 | ||
| Beta | 0.69 | ||
| 3-Year Sharpe Ratio | 0.29 | ||
| 3-Year Sortino Ratio | 0.72 | ||
| Volatility % | 38.31 | ||
| 14-Day RSI | 23.6 | ||
| 14-Day ATR (€) | 0.036189 | ||
| 20-Day SMA (€) | 0.50975 | ||
| 12-1 Month Momentum % | -21.72 | ||
| 52-Week Range (€) | 0.41 - 0.97 | ||
| Shares Outstanding (Mil) | 300.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sensorion SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sensorion SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sensorion SA Frequently Asked Questions
What is Sensorion SA(XPAR:ALSEN)'s stock price today?
The current price of XPAR:ALSEN is €0.41. The 52 week high of XPAR:ALSEN is €0.97 and 52 week low is €0.41.
When is next earnings date of Sensorion SA(XPAR:ALSEN)?
The next earnings date of Sensorion SA(XPAR:ALSEN) is .
Does Sensorion SA(XPAR:ALSEN) pay dividends? If so, how much?
Sensorion SA(XPAR:ALSEN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers